Demonstrates greater fat mass reduction
Although the mechanisms leading to a blood pressure decrease during the treatment with GLP-1 agonists have not been fully elucidated it could be the result of an increased sodium and water excretion and/or inhibition of the RAAS activity 14
In this case, a person would measure a smaller dose into the syringe, which opens up the chance to give too much or too little of the drug, she says
By that, we mean it consistently seeks to do right by its customers and satisfy their expectations
A post-hoc analysis of this trial revealed that tirzepatide users experienced an amelioration of the atherogenic lipoprotein profile with reduction in large triglyceride rich lipid particles, small low-density lipoprotein particles (LDLP) and apolipoprotein B, consistent with the significant improvement of insulin sensitivity
I think we see that with all GLP-1 drugs